Anticancer and antibacterial Activeness of fused Pyrimidines: Newfangled Updates

A Bhatnagar, G Pemawat - Bioorganic Chemistry, 2024 - Elsevier
Pyrimidine-based heterocyclic compounds are garnering substantial interest due to their
essential role as a class of natural and synthetic molecules. These compounds show a …

Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential

Z Xu, L Wang, H Hu - Archiv der Pharmazie, 2024 - Wiley Online Library
Cancer, characterized by uncontrolled cell growth and metastasis, is responsible for nearly
one in six deaths and represents a severe threat to public health worldwide. Chemotherapy …

Computational design of phosphatidylinositol 3-kinase inhibitors

I Rani, A Goyal, M Sharma - ASSAY and Drug Development …, 2022 - liebertpub.com
One of the most sought-after therapeutic targets for treating human cancers is the
phosphoinositide 3-kinase; PI3k is an integral part of the PI3K/protein kinase B signaling …

Exploring the antiproliferative and proapoptotic activities of new pyridopyrimidine derivatives and their analogs

HM Ali, MA Said, S Allam, HA Abdel-Aziz… - Bioorganic & Medicinal …, 2024 - Elsevier
This study investigates a series of newly synthesized compounds, including
pyridopyrimidine derivatives (9a-g), tricyclic pyridotriazolopyrimidine analogs (18a-d), and …

In-Silico Design, Synthesis, and Pharmacological Evaluation of Oxadiazole-Based Selective Cyclo-oxygenase-2 Inhibitors

M Kumar, I Rani, S Mujwar, R Narang… - ASSAY and Drug …, 2023 - liebertpub.com
A series of oxadiazole-based five-membered heterocyclic derivatives was designed and
synthesized with the intent of exclusive cyclo-oxygenase-2 (COX-2) inhibition to acquire anti …

Design, synthesis, characterization, structure-activity relationship, and molecular docking studies of novel 2, 3-dihydropyrimidin-4 (5H)-one and pyrimido [5, 4–c] …

MAMA Reheim, B Ghazal, ISA Hafiz, HSA Rady… - Journal of Molecular …, 2024 - Elsevier
The key starting material, 2-imino-6-phenyl-2, 3-dihydropyrimidin-4 (5H)-one 1, was the
focus of our approach due to the fact that it has an endocyclic active methylene group …

Unlocking the Pharmacological Potential of Benzimidazole Derivatives: A Pathway to Drug Development

J Monga, NS Ghosh, I Rani, R Singh… - Current Topics in …, 2024 - ingentaconnect.com
Heterocyclic molecules have fascinated a massive interest in medicinal chemistry. They are
heterocyclic compounds that have gained significance due to their diverse variety of …

IN SILICO STUDIES OF SOME NEWLY DESIGNED BENZIMIDAZOLETHIAZOLIDINONE BASED ANTAGONISTS OF HUMAN ESTROGEN RECEPTOR.

J Monga, NS Ghosh, S Mujwar, I Rani - Indian Drugs, 2023 - search.ebscohost.com
Breast cancer is globally associated with majority of the women. Indeed, high estrogen
levels are the most common subtype of breast cancer. Three different classes of estrogen …

Recent Advances on Pyrazole-Pyrimidine/Fused Pyrimidine Hybrids with Anticancer Potential (A Review)

S Wang, S Qian, S Wang, Y Zou - Russian Journal of General Chemistry, 2023 - Springer
Cancer, caused by the failure of the mechanism that controls cell growth and proliferation, is
usually associated with severe health issues. Nowadays, chemotherapy still occupies an …

Current Developments of Pyrrolo[2,3-d]pyrimidines with Anticancer Potential (A Review)

ZY Tan, J Deng, QX Ye, ZF Zhang, TY Luo - Russian Journal of General …, 2023 - Springer
Anticancer chemotherapeutics are effective weapons for cancer therapy, but the continuous
emergency of multidrug-resistant cancer and the side effects of current available anticancer …